Vol. 88, Issue 4, 1181-1191, April 2000
Creatine reduces human muscle PCr and pH decrements and
Pi accumulation during low-intensity exercise
Jesús
Rico-Sanz
Nuclear Magnetic Resonance Center, Department of Medical
Biochemistry and Genetics, Panum Institute, University of
Copenhagen, and Copenhagen Muscle Research Center, DK-2100
Copenhagen, Denmark; and Group of Biomedical Applications of Magnetic
Resonance, Department of Biochemistry and Molecular Biology, University
Autonoma of Barcelona, 08193 Bellaterra, Spain
 |
ABSTRACT |
The
purpose of this study was to examine with 31P-magnetic
resonance spectroscopy energy metabolism during repeated plantar flexion isometric exercise (Ex-1-Ex-4) at 32 ± 1 and 79 ± 4%
of maximal voluntary contraction (MVC) before and during a creatine (Cr) feeding period of 5 g/day for 11 days. Eight trained male subjects
participated in the study. ATP was unchanged with Cr supplementation at
rest and during exercise at both intensities. Resting muscle
phosphocreatine (PCr) increased (P < 0.05) from 18.3 ± 0.9 (before) to 19.6 ± 1.0 mmol/kg wet wt after 9 days. At 79% MVC, PCr used, Pi accumulated,
and pH at the end of Ex-1-Ex-4 were similar after 4 and 11 days of
Cr supplementation. In contrast, PCr utilization and Pi
accumulation were lower and pH was higher for exercise at 32% MVC with
Cr supplementation, suggesting aerobic resynthesis of PCr was more
rapid during exercise. These results suggest that elevating muscle Cr
enhances oxidative phosphorylation during mild isometric exercise,
where it is expected that oxygen delivery matches demands and
predominantly slow-twitch motor units are recruited.
nuclear magnetic resonance; oxidative phosphorylation; skeletal
muscle; phosphocreatine; inorganic phosphate
 |
INTRODUCTION |
RECENT STUDIES (4, 19, 21, 22, 43) have demonstrated
that human muscles retain ~10-35% of the 20-30 g of
creatine (Cr) per day supplemented to the habitual diet for 3-6
days, and a recent report showed that 14 days of Cr
feeding (3 g/day) raised the total Cr storage in human muscle as much
as ingesting doses of 20 g/day for 6 days (22). The enlarged
intramuscular total Cr storage after Cr supplementation has been
associated with increments in the work performed in one and repeated
bouts of intense muscle contractions (3, 4, 9, 10), although no
alteration of performance has been observed in some cases (11, 33, 43). The improved muscle performance during repeated exercise after Cr
supplementation was suggested to be due to a higher phosphocreatine (PCr) concentration and to an accelerated rate of PCr resynthesis during the recovery periods (4, 10, 19), and there is recent evidence
that muscle mass might increase during Cr feeding, which might also
play a role in the improvements in muscle work (42, 45). However, a
role for Cr as a controller of oxidative phosphorylation, enabling
higher rates of oxidative metabolism during muscle contraction, has
been basically ignored.
If Cr enhances muscle oxidative phosphorylation during recovery from
ischemic exercise, as suggested by the results of Greenhaff et al.
(19), enhancement of PCr resynthesis should also occur during the
exercise periods after Cr supplementation unless by some unexplained
mechanism this physiological event can only occur during recovery from
muscular contraction. One important condition for the enhancement of
PCr resynthesis during exercise is that there is no limitation of
oxygen supply, because the resynthesis of PCr in human muscle appears
to occur solely in the presence of oxygen (36). Also, control of
oxidative phosphorylation in slow-twitch (ST) and fast-twitch (FT)
fibers might be different (25, 31, 32). Recent reports have shown that
ADP is restricted in the outer mitochondrial membrane in cardiac
myocytes and ST skeletal muscle fibers (37) and that Cr addition
enhanced aerobic phosphorylation only in these fibers (26, 46).
Therefore, after Cr supplementation, enhancement of PCr resynthesis
during aerobic exercise should result in a lesser fall in muscle PCr. These differences should be detected in human muscle during protocols of different recruitment pattern and oxygen availability.
In the present study, the effect of a relatively low Cr dosage (5 g/day) on muscle metabolism was examined with 31P-magnetic
resonance spectroscopy (31P-MRS) at rest, during four bouts
of isometric plantar flexion at light [32% maximal voluntary
contraction (MVC)] and high (79% MVC) intensities, and during
recovery after each bout. The 79% MVC protocol was expected to have
more restriction of oxygen supply and to recruit relatively fewer ST
fibers than would the other because of the higher intensity of the
isometric contraction. It was hypothesized that aerobic phosphorylation
during the exercise periods would be enhanced after Cr supplementation
during light but not intense exercise. The results support this
hypothesis, as evidenced by a smaller net utilization of PCr during
exercise, and suggest that Cr supplementation enhanced aerobic
phosphorylation for light exercise where oxygen delivery could match
demand in ST fibers being recruited.
 |
METHODS |
Subjects.
Eight trained male subjects ranging in age from 23 to 30 yr
participated in this study. Subjects were engaged in endurance training
at least three times a week, and one of them competed in elite
handball. The study was approved by the Ethics Committee of the
University of Copenhagen. Informed consent was obtained from all
subjects after they received a detailed explanation of the procedures
and the risks and discomforts of the experiment.
Experimental design.
In a preliminary visit to introduce the subjects to the experimental
protocols and setup, three maximal voluntary isometric plantar flexion
contractions (MVC) of 3-s duration separated by 2 min were performed.
The highest value of the three trials was taken as the MVC. After being
accustomed to the equipment set up (5), subjects came to the laboratory
on several occasions to complete four exercise bouts (Ex-1-Ex-4)
of 3-min 20-s duration separated by 4 min of rest. Subjects warmed up
for 5 min at 10% MVC followed by 10 min of rest before performing the
repeated exercise bouts. The intensity of the exercise was adjusted
accordingly in subsequent visits until the target intensity was
identified. The aim was for the subjects to endure four exercise bouts,
developing the same tension in each bout and reaching near exhaustion
by the end of the fourth bout so that they were unable to complete a
fifth bout. Similar procedures were followed for the higher intensity
protocol, which consisted of four exercise bouts of 40-s duration
separated by 2 min of rest. These procedures required at least two to
three visits for each protocol.
Once the intensities were identified for each subject, two additional
visits before the Cr supplementation period (Bas) were scheduled for
each protocol to test the reproducibility of measurements and to rule
out a training effect. The two protocols were performed alternatively
on separate days with 1-3 days in between and with 4-6 days
between the two tests for each protocol. The average load for the
high-intensity protocol was 79 ± 4% MVC and that for the
low-intensity protocol was 32 ± 1% MVC. During the Cr supplementation period, the 79% MVC protocol was performed on days
4 (Cr-4) and 11 (Cr-11), and the 32% MVC protocol was
performed on day 9 (Cr-9). During the exercise bouts, force was
recorded by a calibrated strain gauge. Subjects kept force at target
level by watching the strain-gauge readout and by continuous feedback from the experimenter. The same duration and tension for each exercise
bout were applied, thus keeping the total time × tension integral
constant before and after Cr supplementation in both protocols. During
the Cr supplementation period, subjects were given 5 g/day of Cr
monohydrate (Ergomax, Copenhagen, Denmark) for 11 days. The subjects
were requested to ingest the daily dose in three doses after breakfast
(1 g), lunch (2 g), and dinner (2 g) dissolved in 300 ml of warm water.
MRS.
Subjects positioned their dominant leg in the ergometer in a 2.9-T,
26-cm-bore-diameter, and 80-cm-bore-length Magnex magnet that was
interfaced to an Otsuka VivoSpec spectrometer. A two-turn inductively
driven surface radio frequency coil, 39 mm in diameter, was located
over the belly of the gastrocnemius muscle. The area of
the muscle described by the circumference of the surface coil was
marked, and the distance from the fossa poplitea was measured the first
day. In subsequent visits, the coil was placed exactly at the same
location. Shimming was performed by preshimming on the proton signal
from muscle water and fine shimming on the PCr signal.
Spectra of phosphorus containing metabolites were obtained at 49.85 MHz. For spectra acquisition, a pulse width of 60 ms (90°) with an
interpulse delay of 5 s was employed. Data were collected in 2,048 data
points and with a spectral width of 10 kHz. Four free induction decays
(FIDs) were collected for each spectrum during exercise at 32% MVC and
only one FID for exercise at 79% MVC. During the recovery from the
79% MVC protocol, a spectrum consisted of the sum of two FIDs. Before
Fourier transformation, the data were multiplied by 5-Hz exponential
line broadening. Baseline correction was obtained by convolution
difference. Integration of the peak areas was performed by a
least-squares fitting routine assuming a Lorentzian line shape and then
corrected for partial saturation. Saturation factors were obtained on
all subjects at rest with an interpulse delay of 25 s. A
total of nine saturation factor measurements were obtained for each
subject. The average saturation factor for Pi, PCr, and ATP
was 1.25 ± 0.02, 1.37 ± 0.02, and 1.14 ± 0.01, respectively.
The unsaturated areas for all metabolites were converted to
concentrations by assuming average integrated ATP signal for all subjects during the baseline period to correspond to a resting concentration of 5.5 mmol/kg wet wt. Intracellular pH during the exercise periods was calculated from the chemical shift difference of
the Pi peak with respect to the PCr peak (2). The
parameters for the time course of PCr resynthesis were determined by
fitting the points to a monoexponential growth curve.
Statistics.
Values are expressed as means ± SE. Differences between results of
the two protocols during the first and second visits of the Bas and
between before and after Cr for each protocol were analyzed by
repeated-measures analysis of variance. A post hoc Scheffé's
F-test was used to analyze any significant difference. Differences were considered significant at the 5% probability level.
Because no significant differences between the rates of PCr breakdown
and recovery, Pi accumulation, and pH changes were found
between the two baseline visits for either of the protocols, the
average of all the values for all parameters for these two visits was
taken for comparison with the values during the supplementation period.
 |
RESULTS |
Resting muscle metabolite concentrations.
Muscle ATP and Pi remained unchanged during the
supplementation period (Table 1). Average
resting muscle PCr during baseline increased (P < 0.05 and
P < 0.01, respectively) after the 9th and 11th days. Assuming
a PCr-to-total Cr (TCr) ratio of 0.65 and 0.61 before and after the
supplementation period, respectively (values obtained from 84 subjects
of Refs. 3, 9, 14, 24; assuming 77% muscle water), the free Cr was
calculated to be 9.9 ± 0.5 mmol/wet wt at Bas and 12.5 ± 0.6 and 12.4 ± 0.6 mmol/kg wet wt after Cr-9 and Cr-11, respectively.
The calculated increase in TCr amounted to 14% of the resting value.
View this table:
[in this window]
[in a new window]
|
Table 1.
Effect of oral creatine feeding of 5 g/day on resting muscle ATP, PCr,
and Pi during baseline period and after 4, 9, and 11 days
of Cr supplementation
|
|
Muscle metabolism.
The ATP changes during exercise were not significantly altered by Cr
supplementation in either of the protocols. The dynamic changes of PCr
during the exercise periods during the 79% MVC protocol are shown in
Fig. 1. The net PCr utilization during
Ex-1-Ex-4 (11.9 ± 0.8, 13.9 ± 1.1, 14.9 ± 1.3, and 15.9 ± 1.3 mmol/kg wet wt, respectively) did not change after Cr-4 and Cr-11.
However, during the 32% MVC protocol, the net PCr breakdown during
Ex-1 and Ex-2 (4.6 ± 0.5 and 7.7 ± 0.8 mmol/kg wet wt,
respectively) was significantly lower (P < 0.05 and P < 0.01, respectively) after Cr-9 (3.5 ± 0.6 and 5.7 ± 0.8 mmol/kg
wet wt, respectively; Fig. 2). Also, during
Ex-3, the net muscle PCr utilized was lower between 50 s and the end of
exercise after Cr-9, although the differences were only significant at
72.5 (P < 0.05), 92.5 (P < 0.05), and 172.5 s
(P < 0.05), and there was a strong tendency at 52.5 (P = 0.05) and 192.5 s (P = 0.06) into the exercise.
During Ex-4, PCr used was also significantly lower at 92.5 (P < 0.05) and 112.5 s (P < 0.05). After this time, the net
PCr utilized was not significantly lower after Cr-9 compared with Bas.
During the 79% protocol, the half time of PCr resynthesis was
lengthened (P < 0.05) after Cr-11 compared with Bas during
recovery from Ex-1 and Ex-4, whereas it was lengthened (P < 0.05) during recovery from Ex-2 after Cr supplementation during the
32% MVC protocol (Tables 2 and
3).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 1.
Muscle phosphocreatine (PCr) during 4 exercise (Ex) periods of 40 s at
intensity of 79 ± 4% maximal voluntary contraction (MVC) separated
by 2 min of rest before (Bas) and after 4 (Cr-4) and 11 (Cr-11) days of
creatine supplementation (5 g/day). Values are means ± SE.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 2.
Muscle PCr during 4 Ex periods of 200 s at intensity of 32 ± 1% of
MVC separated by 4 min of rest at Bas and after 9 days of creatine
supplementation (5 g/day; Cr-9). Values are means ± SE. Significant
difference in net PCr breakdown by that point in time between Bas and
Cr-9: # P < 0.01; * P < 0.05.
|
|
View this table:
[in this window]
[in a new window]
|
Table 2.
Half time of PCr resynthesis during recovery periods after 4 isometric
plantar flexion exercise bouts at an intensity of 79% MVC at Bas and
after Cr-4 and Cr-11
|
|
View this table:
[in this window]
[in a new window]
|
Table 3.
Half time of PCr resynthesis during recovery periods after 4 isometric
plantar flexion exercise bouts at an intensity of 32% MVC at Bas and
after Cr-9
|
|
The change in muscle Pi accumulation at the end of the
exercise bouts during the 79% MVC protocol (Ex-1, 4.6 ± 0.8; Ex-2, 6.1 ± 1.0 Ex-3, 6.0 ± 0.9; and Ex-4, 6.7 ± 1.0 mmol/kg
wet wt) was not significantly altered (Fig.
3). On the other hand, muscle Pi accumulation during the 32% MVC protocol before Cr
supplementation of 3.9 ± 0.2 (Ex-1), 5.3 ± 0.7 (Ex-2), 8.8 ± 1.3 (Ex-3), and 11.1 ± 1.3 mmol/kg wet wt (Ex-4) was significantly lower
(P < 0.01) at the end of Ex-1, Ex-2, and Ex-3 and tended to
be lower (P = 0.06) at the end of Ex-4 after Cr
supplementation. The muscle Pi accumulation was
significantly lower during a large part of all the exercise periods in
this protocol (Fig. 4).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Muscle Pi during 4 Ex periods of 40 s at intensity of 79 ± 4% MVC separated by 2 min of rest at Bas and after Cr-4 and Cr-11.
Values are means ± SE. * Significant difference in net
Pi accumulation by that point in time between Bas and Cr-4,
P < 0.05.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 4.
Muscle Pi during 4 Ex periods of 200 s at intensity of 32 ± 1% of MVC separated by 4 min of rest at Bas and after Cr-9.
Significant difference in the net Pi accumulation by that
point in time during exercise between Bas and Cr-9:
# P < 0.01; * P < 0.05
|
|
The resting muscle pH did not change during the supplementation period
(mean 7.05 ± 0.01; range 7.04-7.06). The pH changes during the
four exercise periods at 79% MVC and the end-exercise pH in Bas of
7.03 ± 0.03, 6.99 ± 0.03, 6.98 ± 0.02, and 6.97 ± 0.03 for
Ex-1, Ex-2, Ex-3, and Ex-4, respectively, were similar to those
observed after Cr-4 and Cr-11 (Fig. 5). The
time course of muscle pH during the 32% MVC protocol is shown in Fig.
6. The muscle pH was higher after Cr
supplementation at several time points during the exercise periods.
Muscle pH values at the end of Ex-1 (6.97 ± 0.03), Ex-2 (6.96 ± 0.02), Ex-3 (6.88 ± 0.03), and Ex-4 (6.76 ± 0.03) were higher after
Cr supplementation, with the differences reaching statistical
significance (P < 0.05, P < 0.01, and P < 0.05, respectively) with the exception of Ex-2 (P = 0.09).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 5.
Muscle pH during 4 Ex periods of 40 s at intensity of 79 ± 4% of MVC
separated by 2 min of rest at Bas and after Cr-4 and Cr-11. Values are
means ± SE.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 6.
Muscle pH during 4 Ex periods of 200 s at intensity of 32 ± 1% of
MVC separated by 4 min of rest at Bas and after Cr-9. Values are means ± SE. Significant difference between pH values for Bas and
Cr-9,* P < 0.05.
|
|
For further inspection of the kinetic changes of PCr utilization and
resynthesis and of Pi and H+ accumulation, data
for each subject were averaged for the four exercise and recovery
bouts. Because the responses for Cr-4 were not different
from those of Bas, only the data for Bas and Cr-11 during the 79% MVC
protocol are shown for clarity. The average PCr utilization for
Ex-1-Ex-4 did not change after Cr-11 compared with Bas (Fig.
7A). However, the half time of PCr
resynthesis was lengthened (P < 0.01) after Cr-11 (18.4 ± 1.1 vs. 22.3 ± 1.4 s). The analysis revealed that the amount of PCr
resynthesized was not significantly altered up until 30 s of recovery
(8.8 ± 0.7 vs. 7.8 ± 0.8 mmol/kg wet wt in Bas and Cr-11,
respectively). However, the amount of PCr resynthesized from 30 to 120 s was larger (P < 0.05) after Cr-11 (4.0 ± 0.4 vs. 4.6 ± 0.4 mmol/kg wet wt). The average Pi response for
Ex-1-Ex-4 did not change significantly after Cr-11 (Fig.
8A). The rate of Pi
accumulation during the first 20 s was 0.127 ± 0.021 in Bas
and 0.183 ± 0.030 mmol · kg wet
wt
1 · s
1 after Cr-11,
and during the last 20 s of contraction it was 0.171 ± 0.028 and
0.204 ± 0.034 mmol · kg wet
wt
1 · s
1 in Bas and
Cr-11, respectively. H+ was not significantly changed (Fig.
9A).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 7.
Average muscle PCr of 4 Ex and recovery bouts at the intensities of 79 ± 4% (A) and 32 ± 1% of MVC (B) at Bas and after
Cr-11 (A) and Cr-9 (B). Values are means ± SE.
* Significant (P < 0.05) increase of half time of PCr
resynthesis in 79% MVC protocol (A) and decrease in net PCr
breakdown until 120 s in 32% MVC protocol (B) after Cr
supplementation.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 8.
Average muscle Pi of 4 four Ex and recovery bouts at
intensities of 79 ± 4% (A) and 32 ± 1% of MVC (B)
at Bas and after Cr-11 (A) and Cr-9 (B). Values are
means ± SE. # Significant decrease of rate of
Pi accumulation until 120 s in 32% MVC protocol after Cr
supplementation, P < 0.01.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 9.
Average muscle H+ of 4 Ex and recovery bouts at intensities
of 79 ± 4% (A) and 32 ± 1% of MVC (B) at Bas and
after Cr-11 (A) Cr-9 (B). Values are means ± SE.
# Significant decrease of rate of H+
accumulation from 120 to 200 s in 32% MVC protocol after Cr
supplementation, P < 0.01.
|
|
Averaging the values for Ex-1-Ex-4 during the 32% MVC protocol
revealed that the PCr degradation from 0 to 120 s was lower (P < 0.05) after Cr supplementation (5.2 ± 0.7 vs. 4.0 ± 0.5 mmol/kg wet wt). The net degradation from 120 s to the end of exercise was not
different (4.4 ± 0.5 vs. 4.1 ± 0.5 mmol/kg wet wt; Fig. 7B). The average half time of PCr resynthesis did not change
significantly after Cr supplementation (18.4 ± 0.9 vs. 17.4 ± 1.1 s
in Bas and Cr-9, respectively). The average rate of Pi
accumulation for Ex-1-Ex-4 up to ~120 s of contraction (0.031 ± 0.005 · mmol.kg wet
wt
1 · s
1) was
also lower (P < 0.01) after Cr-9 (0.016 ± 0.006 mmol · kg wet
wt
1 · s
1; Fig.
8B). The rate of Pi accumulation from ~120 s to
the end of exercise tended to be lower (P = 0.06) after Cr-9
(0.048 ± 0.006 vs. 0.033 ± 0.006 mmol · kg wet
wt
1 · s
1). The
rates of H+ buffered (0-50 s) and accumulation
(50-120 s) to ~120 s did not change after Cr-9, but the rate of
H+ accumulation from 120 s until the end of contraction was
significantly lower (P < 0.01) after Cr-9 (0.41 ± 0.08 vs.
0.22 ± 0.09 nM/s; Fig. 9B).
 |
DISCUSSION |
The main aims of this study were to investigate the effects of Cr
supplementation at a daily dose of 5 g on resting muscle metabolites
and muscle energy metabolism during repeated exercise of different
intensities. It was hypothesized that an effect of Cr on aerobic
metabolism would occur during the exercise periods for light but not
for heavy isometric exercise. The results support this hypothesis, as
evidenced by the lower PCr breakdown, Pi accumulation, and
pH drop in the lower intensity protocol after Cr feeding.
During the Cr supplementation period, the ATP values remained
unchanged, which is in agreement with the results of other studies (4,
10, 13, 19, 21, 22, 43). Despite the comparatively low daily dose of Cr
given in the present study, intramuscular PCr increased 1.3 mmol/kg wet
wt after 9 days of Cr feeding. It is also very likely that in this
study the muscle free Cr increased more than PCr did, as has been
demonstrated in all the recent studies (4, 10, 13, 19, 21, 22, 43).
Calculations showed that, after Cr supplementation, ~2.5 mmol/kg wet
wt of free Cr were deposited in the muscle examined. Assuming 30 kg muscle mass and the same uptake in all muscles as occurred in the
gastrocnemius, ~16 g of Cr would be retained by the 11th day, which
corresponded to 29% of the dose given. Studies have shown that
10-35% of the Cr supplement is retained for doses ranging from 3 to 30 g during periods of up to 44 days (4, 10, 13, 19, 21, 22, 35,
43). It is clear from these experiments that Cr entry into and
retention by muscle can be accomplished by different regimens, but a
large part of the Cr supplement is lost. Human muscle cells take up Cr
from blood by a Na+-dependent and
Na+-independent specific transport process (27). The
Na+-dependent transport is downregulated by physiological
plasma Cr (27), which might be a limitation when very high doses are given for a prolonged period. Insulin (23), exercise (21), vitamin E
(15), and high-carbohydrate feeding have been shown to have a positive
influence on the uptake of Cr in muscle (16, 17). The subjects' diet
and activity were not recorded in the present experiment, but they were
requested to keep the same activity and food intake patterns during the
course of the study. Nevertheless, the significant gain in muscle PCr
of ~7% indicates the supplementation was successful.
The effect of Cr supplementation on muscle energy metabolism was
investigated noninvasively during two protocols of repeated isometric
contraction: one at high intensity (79% of MVC) and another at low
intensity (32% of MVC). During high-intensity isometric contraction, a
large number of fibers (both ST and FT) must be recruited, and above
50-70% of MVC, a large reduction in blood flow during exercise is
expected. For instance, during contraction of the quadriceps at 50%
MVC, lower blood flow and muscle oxygen uptake were observed compared
with contraction at 25% MVC (14). Furthermore, endurance time of the
quadriceps muscle during contraction at 67% of MVC was the same with
or without circulatory occlusion (12), indicating that above ~67%
MVC local ischemia occurs. Because PCr resynthesis is dependent
on adequate blood flow and oxygen delivery (36), Cr supplementation
would not be expected to enhance PCr resynthesis during exercise at
79% MVC where such a limitation is likely to occur. The findings at
this high intensity are consistent with this hypothesis. That is, the
PCr decrease, Pi accumulation, and pH change during the
four exercise bouts at Bas were not different from those after Cr-4 and
Cr-11. In contrast, the 32% MVC protocol recruits a fewer number of
fibers, causing significantly less restriction of blood flow and muscle oxygenation (14). Supplementation, in this case, is expected to enhance
the resynthesis of PCr, thereby reducing the PCr loss, Pi
accumulation, and pH fall during light exercise as found in the present study.
It has been shown that the rate of PCr degradation of rat and human
muscle follows a monoexponential decay during submaximal isotonic
exercise of different intensities (28, 29). In the present study, PCr
degradation during isometric exercise at 32% MVC was more complex. Up
to ~120 s of exercise, the PCr decline followed a monoexponential
pattern, but from then on its decay was linear. Furthermore, the data
showed a progressive tendency for the monoexponential decay to be
linear with the number of bouts. Cr supplementation tended to attenuate
this pattern. The explanation for this complex response currently is
unknown. A possibility is a progressive change in the type and number
of muscle fibers recruited during light isometric exercise as fatigue develops. At low exercise intensities, there is an orderly recruitment of ST, FTa, and FTb fibers as time progresses to fatigue
(47). The recruitment of a larger number of FT fibers
with time and in repeated bouts could have produced a progressive
limitations in blood flow and oxygen delivery to working muscle,
thereby changing PCr kinetics from monoexponential to a linear dynamic.
Experiments on isolated mitochondria have shown that PCr decreases
linearly when mitochondrial respiration exhausts the oxygen available
and oxidative phosphorylation becomes oxygen limited (20). Alterations in H+ per se do not appear to be involved. The finding that
Cr supplementation affected the net PCr utilization and Pi
accumulation but did not affect pH during the monoexponential decay
period excludes any effect of H+ on the kinetics of PCr
during this time. Furthermore, H+ accumulation was lower
from 120 to 200 s after Cr supplementation, suggesting that the rate of
H+ production through anaerobic glycolysis was lower, but
the PCr degradation rate was not changed by supplementation during this later period of low-intensity exercise. In other studies, Balsom et al.
(4) found a lower muscle lactate accumulation at the end of repeated
6-s bouts of supramaximal cycling, whereas Febbraio et al. (13) found
no change in glycogen degradation or lactate accumulation after five
1-min bouts after Cr supplementation. These controversial findings
would need to be clarified in future research. Thus it is proposed
that, whereas the oxygen delivery was not impeded and a larger relative
proportion of ST fibers was recruited, oxidative phosphorylation during
the exercise periods was likely enhanced after Cr supplementation.
Contrary to the present suggestion of an increment in oxidative
phosphorylation during the exercise periods, Balsom et al. (4) proposed
that the lower net PCr breakdown at the end of repeated bouts of
maximal exercise was due to higher resynthesis of PCr during the
recovery periods as demonstrated by Greenhaff et al. (19) during
recovery from ischemic exercise. However, other results obtained in
Greenhaff's laboratory with 31P-MRS and biochemical
analysis have shown that the amount of PCr resynthesized during
recovery from ischemic and nonischemic exercise in tibialis and vastus
lateralis, respectively, did not change after Cr supplementation (10,
18), whereas no explanation for the discrepant results has been given
(10). Also, Balsom et al. (4) measured PCr from muscle biopsies
obtained only before the first bout and after the fifth bout, and the
recovery periods between exercise bouts were 30 s, whereas the results of Greenhaff et al. (19) showed no change in the rate of PCr resynthesis during the first minute of recovery. A recent study showed
that the amount of PCr resynthesized during 2 min of recovery from a
20-s sprint was not affected but that a significant relationship was
found between the percent increase in TCr and the percent change in PCr
after 2 min of recovery after Cr supplementation (43). If the amount of
PCr is increased after Cr supplementation only after ~2 min of
recovery from exercise, the half time of PCr resynthesis would be
lengthened. Indeed, estimation of the half time of PCr resynthesis from
the PCr changes in vastus lateralis muscle of the responders to Cr in
the study of Greenhaff et al. gave values of ~28 s before Cr
supplementation and of ~40 s after Cr supplementation. Slower
resynthesis rates of PCr in tibialis muscle after Cr supplementation
have also been shown with 31P-MRS during 6-min recovery
from different workloads (24). In the present study, the results of the
average of the four recovery bouts indicate that PCr resynthesis might
be enhanced during the latter part of the recovery from high-intensity
isometric exercise in agreement with the results of Greenhaff et al.
during recovery from ischemic exercise. The lengthening of the PCr
resynthesis rate cannot be explained by an effect of pH, because the
end-exercise pH was not different from resting values in this protocol.
In support of the absence of an effect of pH on PCr resynthesis rate is
that, during the 32% MVC protocol, the half time of PCr resynthesis was not different with repeated bouts of exercise despite a progressive lower end-exercise pH. Greenhaff et al. also discarded this possibility when they observed higher muscle lactate at the end of exercise after
Cr loading. To explain the enhancement of PCr resynthesis after only 2 min of recovery, Greenhaff et al. (19) argued that, immediately after
maximal exercise, free Cr is above the Michaelis-Menten constant
(Km) of creatine kinase (CK) for Cr and that
consequently a higher rate of PCr resynthesis is not expected after Cr
supplementation. They reasoned that small changes in free
Cr concentration as the free Cr starts decreasing toward the
Km value can play a larger role in the rate of PCr
resynthesis. Also, if the Cr that is taken up after supplementation and
that is released from the breakdown of PCr has much greater access to
the site of phosphorylation than does any other free Cr (39), any
effect of free Cr on oxidative phosphorylation during the recovery
period was more likely to be present during the 79% MVC protocol in
the present study because the Cr released from PCr degradation was not
different after Cr supplementation. On the other hand, the Cr released
from PCr breakdown during exercise in the 32% MVC protocol was likely
lower after Cr supplementation. Therefore, the total free Cr at the end
of exercise in this protocol was probably not different compared with
before supplementation. Following the previous argument of fiber-type
recruitment during exercise and the arguments of Greenhaff et al. and
Savabi (39), it is also possible to reconcile why Cr might have
affected oxidative metabolism only during the exercise period of the
32% MVC protocol and during the recovery of the 79% MVC protocol in
the present study, as evidenced by the pooled data of the four exercise
and recovery periods.
The mechanism by which oxidative phosphorylation in human muscle might
have been increased after Cr supplementation might not differ from that
of animal muscle. The enhancement of respiration by Cr in muscle was
first observed by Thunberg and supported by findings of Katz (in Ref.
8) and was strengthened by the observations of Belitser and Tsybakova
(6). The phenomenon was proposed to occur via CK in the mitochondrial
intermembrane space (Mit-CK) and a Cr-PCr shuttle, which, by some
mechanism yet undiscovered, carried Cr to mitochondria and provided PCr
to myofibrils, sarcolemma, and sarcoplasmic reticulum where the energy
is needed during muscle contraction (7, 8, 38). Later
investigations on skeletal muscle cell cultures and cardiomyocytes also
confirmed that additional Cr increased the rate of oxidative
phosphorylation and highlighted the role of the CK system in the
transport of intracellular energy from mitochondria to myofibrils and
other sites of energy utilization (8, 37, 38, 41). In cardiomyocytes,
the higher respiration rates and higher rates of PCr production
observed after Cr addition were suggested to be caused by an
amplification of the sensitivity of respiration to ADP
(Km: 300 µM before Cr vs. 36 µM after Cr) (40)
because of the coupling of Mit-CK, adenine nucleotide translocase, and
oxidative phosphorylation (37). In skeletal muscle, differences in
regulation of oxygen consumption in FT and ST muscle were first suggested by Meyer et al. (31) and Kushmerick et al. (25). Meyer et al.
(31) proposed that perhaps the mitochondria in the two fiber types were
not the same. It was latter reported that ADP was restricted in the
outer mitochondrial membrane in cardiac myocytes and ST skeletal muscle
fibers (37) and that this restriction could be the explanation for the
controlling role of Cr on oxidative phosphorylation in these fibers and
not in FT fibers (26, 46). Meyer and Foley (32) have also reported differences in the regulation of oxygen consumption in ST and FT
fibers. Moreover, the Mit-CK of the human gastrocnemius muscle has been
shown to qualitatively and kinetically resemble that of heart muscle
(1, 40). The M-CK activity is also higher in human trained vs.
untrained muscle (1) and higher in ST compared with FT muscle (48).
Therefore, there is a higher likelihood to observe an effect of Cr on
oxidative phosphorylation during exercise demanding larger relative
involvement of ST fibres in highly active humans. The present results
show that this was likely the case. In contrast, after assuming that
the increase in TCr concentration after Cr supplementation was larger
in FT fibers, Casey et al. (10) proposed increased mitochondrial ATP
production in this fiber type (10). However, their own data do not
support larger increases in TCr concentration in FT fibers after Cr
supplementation (Table 2 in Ref. 10). Also, results from animal muscle
showed that depletion of up to 90% of TCr had no effect on aerobic
metabolism in FT fibers (30), and it was suggested that in FT fibers
the CK system acts as a simple buffer of adenine nucleotide levels (29,
30). Furthermore, in support of the contention that the effect of Cr on
oxidative metabolism is confined to the ST fibers are the results of a
recent report that showed a correlation between the percentage of ST
fibers and the enhancement of oxidative phosphorylation after Cr was
added to human skinned fibers obtained after exercise (44). An
additional or sinergistic possibility is the proposed regulation of
PCr/Cr on AMP-activated protein kinase (AMPK) as the control mechanism
of CK in muscle (34). According to this novel mechanism, during the
32% MVC protocol a larger decrease in PCr/Cr during exercise after Cr
feeding would have inhibited PCr breakdown and enhanced oxidation of
fatty acids by the dual control of AMPK inhibiting MM CK isoform and
acetyl-CoA carboxylase, the latter eventually causing a drop in
malonyl-CoA relieving the inhibition of carnitine palmitoyltransferase
I. The possible ischemic conditions during the exercise
periods of the 79% MVC protocol would have prevented oxidative
phosphorylation from taking place. However, because PCr/Cr was lower
after Cr feeding, particularly during the latter phase of recovery,
this might have enhanced the oxidation of fatty acids and therefore
increase the rate of PCr resynthesis. Possible differences in the
control of AMPK in ST and FT fibers by PCr/Cr remain to be discovered,
which might add to explain further the role of Cr in human muscle
energy metabolism.
In conclusion, the results of this study demonstrate that adding a
daily dose of 5 g Cr to the habitual diet increases muscle PCr in 9 days. Net muscle PCr utilization, Pi accumulation, and pH
drop were reduced during repeated bouts of relative low-intensity exercise leading to exhaustion after Cr supplementation, indicating that muscle oxidative phosphorylation during contraction is increased by Cr supplementation. This did not occur at high-intensity exercise. This difference is likely the result of better matching of oxygen delivery with demand and greater recruitment of ST fibers.
 |
ACKNOWLEDGEMENTS |
During the completion of this research project, J. Rico-Sanz was
partly funded by the Copenhagen Muscle Research Center, and by the
Spanish Ministry of Education and Culture under project SAF96-0147 of
the Spanish Interministerial Commission of Science and Technology.
 |
FOOTNOTES |
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: J. Rico-Sanz,
Group of Biomedical Applications of Magnetic Resonance, Dept. of
Biochemistry and Molecular Biology, Facultat de Ciencies, Universitat
Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain (E-mail:
j.rico-sanz{at}proton.uab.es).
Received 2 October 1998; accepted in final form 28 October 1999.
 |
REFERENCES |
1.
Apple, F. S.,
and
Tesch P. A.
CK and LD isozymes in human single muscle fibers in trained athletes.
J. Appl. Physiol.
66:
2717-2720,
1989[Abstract/Free Full Text].
2.
Arnold, D. L.,
Matthews P. M.,
and
Radda G. K.
Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P-NMR.
Magn. Reson. Med.
1:
307-315,
1984[ISI][Medline].
3.
Balsom, P. D.,
Ekblom B.,
Söderlund K.,
Sjödin B.,
and
Hultman E.
Creatine supplementation and dynamic high-intensity intermittent exercise.
Scand. J. Med. Sci. Sports
3:
143-149,
1993.
4.
Balsom, P. D.,
Söderlund K.,
Sjödin B.,
and
Ekblom B.
Skeletal muscle metabolism during short duration high intensity exercise: influence of creatine supplementation.
Acta Physiol. Scand.
154:
303-310,
1995[ISI][Medline].
5.
Bangsbo, J.,
Johansen L.,
Quistorff B.,
and
Saltin B.
NMR and analytic biochemical evaluation of CrP and nucleotides in the human calf during muscle contraction.
J. Appl. Physiol.
74:
2034-2039,
1993[Abstract/Free Full Text].
6.
Belitser, V. A.,
and
Tsybakova E. T.
The mechanism of phosphorylation associated with respiration.
Biochimiya
4:
516-534,
1939.
7.
Bessman, S. P.,
and
Fonyo A.
The possible role of mitochondrial bound creatine kinase in regulation of mitochondrial respiration.
Biochem. Biophys. Res. Commun.
22:
597-602,
1966[ISI][Medline].
8.
Bessman, S. P.,
and
Geiger P. J.
Transport of energy in muscle: the phosphorylcreatine shuttle.
Science
211:
448-452,
1981[Abstract/Free Full Text].
9.
Birch, R.,
Noble D.,
and
Greenhaff P. L.
The influence of dietary creatine supplementation on performance during repeated bouts of maximal isokinetic cycling in man.
Eur. J. Appl. Physiol.
69:
268-270,
1994.
10.
Casey, A.,
Constantin-Teodosiu D.,
Howell S.,
Hultman E.,
and
Greenhaff P. L.
Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans.
Am. J. Physiol. Endocrinol. Metab.
271:
E31-E37,
1996[Abstract/Free Full Text].
11.
Cooke, W. H.,
Grandjean P. W.,
and
Barnes W. S.
Effect of oral creatine supplementation on power output and fatigue during bicycle ergometry.
J. Appl. Physiol.
78:
670-673,
1995[Abstract/Free Full Text].
12.
Edwards, R. H. T.,
Nordesjö L. O.,
Koh D.,
Harris R. C.,
and
Hultman E.
Isometric exercise
factors influencing endurance and fatigue.
In: Muscle Metabolism During Exercise: Advances in Experimental Medicine and Biology, edited by Pernow B.,
and Saltin B.. New York: Plenum, 1971, vol. II, p. 357-360.
13.
Febbraio, M. A.,
Flanagan T. R.,
Snow R. J.,
Zhao S.,
and
Carey M. F.
Effect of creatine supplementation on intramuscular TCr, metabolism and performance during intermittent, supramaximal exercise in humans.
Acta Physiol. Scand.
155:
387-395,
1995[ISI][Medline].
14.
Gaffney, F. A.,
Sjøgaard G.,
and
Saltin B.
Local and central hemodynamic response to sustained static contraction in man.
Acta Physiol. Scand.
138:
249-258,
1990[ISI][Medline].
15.
Gerber, G. B.,
Gerber G.,
Koszalka T. R.,
and
Emmel V. M.
Creatine metabolism in vitamin E deficiency in the rat.
Am. J. Physiol.
202:
453-460,
1962.
16.
Green, A. L.,
Hultman E.,
Macdonald I. A.,
Sewell D. A.,
and
Greenhaff P. L.
Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans.
Am. J. Physiol. Endocrinol. Metab.
271:
E281-E286,
1996.
17.
Green, A. L.,
Simpson E. J.,
Littlewood J. J.,
Macdonald I. A.,
and
Greenhaff P. L.
Carbohydrate ingestion augments creatine retention during creatine feeding in humans.
Acta Physiol. Scand.
158:
195-202,
1996[ISI][Medline].
18.
Greenhaff, P. L.,
Bodin K.,
Harris R.,
Hultman E.,
Jones D. A.,
Mcintyre D. B.,
Söderlund K.,
and
Turner D. L.
The influence of oral creatine supplementation on muscle phosphocreatine resynthesis following intense contraction in man (Abstract).
J. Physiol. (Lond.)
467:
75P,
1993.
19.
Greenhaff, P. L.,
Bodin K.,
Söderlund K.,
and
Hultman E.
Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis.
Am. J. Physiol. Endocrinol. Metab.
266:
E725-E730,
1994[Abstract/Free Full Text].
20.
Gyulai, L. Z.,
Roth J. S.,
Leigh J. R.,
and
Chance B.
Bioenergetic studies of mitochondrial oxidative phosphorylation using 31phosphorus NMR.
J. Biol. Chem.
260:
3947-3954,
1985[Abstract/Free Full Text].
21.
Harris, R.,
Söderlund K.,
and
Hultman E.
Elevation of creatine in resting and exercise muscles of normal subjects by creatine supplementation.
Clin. Sci. (Colch.)
83:
367-374,
1992[Medline].
22.
Hultman, E.,
Söderlund K.,
Timmons J. A.,
Cederblad G.,
and
Greenhaff P. L.
Muscle creatine loading in men.
J. Appl. Physiol.
81:
232-237,
1996[Abstract/Free Full Text].
23.
Koszalka, T. R.,
and
Andrew C. L.
Effect of insulin on the uptake of creatine-L-14C by skeletal muscle in normal and x-irradiated rats.
Proc. Soc. Exp. Biol. Med.
139:
1265-1271,
1972[Medline].
24.
Kreis, R.,
Koster M.,
Kamber M.,
Felbinger J.,
Slotboom J.,
Walker G.,
Hoppeler H.,
and
Boesch C.
Effect of creatine supplementation upon muscle metabolism studied by 1H- and 31P-MRS, MRI, exercise performance testing and clinical chemistry.
In: Proceedings of the International Society of Magnetic Resonance in Medicine Annual Meeting New York April 2-May 3 1996. Berkeley, CA: International Society of Magnetic Resonance in Medicine, 1996, vol. 1, p. 25.
25.
Kushmerick, M.,
Meyer R. A.,
and
Brown T. R.
Regulation of oxygen consumption in fast- and slow-twitch muscle.
Am. J. Physiol. Cell Physiol.
263:
C598-C606,
1992[Abstract/Free Full Text].
26.
Kuznetsov, A. V.,
Tiivel T.,
Sikk P.,
Kaambre T.,
Kay L.,
Danahsrad Z.,
Rossi A.,
Kadaja L.,
Peet N.,
and
Saks V. A.
Striking differences between the kinetics of regulation of respiration by ADP in slow-twitch and fast-twitch muscles in vivo.
Eur. J. Biochem.
241:
909-915,
1996[ISI][Medline].
27.
Loike, J. D.,
Zalutsky D. L.,
Kaback E.,
Miranda A. F.,
and
Silverstein S. C.
Extracellular creatine regulates creatine transport in rat and human muscle cells.
Proc. Natl. Acad. Sci. USA
85:
807-811,
1988[Abstract/Free Full Text].
28.
McCann, D. J.,
Molé P. A.,
and
Caton J. R.
Phosphocreatine kinetics in humans during exercise and recovery.
Med. Sci. Sports Exerc.
27:
378-387,
1994.
29.
Meyer, R. A.
A linear model of muscle respiration explains monoexponential phosphocreatine changes.
Am. J. Physiol. Cell Physiol.
254:
C548-C553,
1988[Abstract/Free Full Text].
30.
Meyer, R. A.
Linear dependence of muscle phosphocreatine kinetics on total creatine content.
Am. J. Physiol. Cell Physiol.
257:
C1149-C1157,
1989[Abstract/Free Full Text].
31.
Meyer, R. A.,
Brown T. R.,
and
Kushmerick M. J.
Phosphorus nuclear magnetic resonance of fast- and slow-twitch muscle.
Am. J. Physiol. Cell Physiol.
248:
C279-C287,
1985[Abstract/Free Full Text].
32.
Meyer, R. A.,
and
Foley J. M.
Testing models of respiratory control in skeletal muscle.
Med. Sci. Sports Exerc.
26:
52-57,
1994[ISI][Medline].
33.
Odland, L. M.,
MacDougall J. D.,
Tarnopolsky M.,
Elorriaga A.,
and
Borgamann A.
The effect of oral Cr supplementation on muscle [PCr] and short-term maximum power output.
Med. Sci. Sports Exer.
29:
216-219,
1997[ISI][Medline].
34.
Ponticos, M.,
Lu Q. L.,
Morgan J. E.,
Hardie D. G.,
Partridge T. A.,
and
Carling D.
Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle.
EMBO J.
17:
1688-1699,
1998[ISI][Medline].
35.
Rose, W. C.,
and
Dimmitt F. W.
Experimental studies on creatine and creatinine. VII. The fate of creatine and creatinine when administered to man.
J. Biol. Chem.
XXVI:
345-353,
1916.
36.
Sahlin, K.,
Harris R.,
and
Hultman E.
Creatine kinase equilibrium and lactate content compared with muscle pH in tissue samples obtained after isometric exercise.
Biochem. J.
152:
173-180,
1975[ISI][Medline].
37.
Saks, V. A.,
Belikova Y. O.,
Kuznetsov A. V.,
Khuchua Z. A.,
Branishte T. H.,
Semenovsky M. L.,
and
Naumov V. G.
Phosphocreatine pathway for energy transport: ADP diffusion and cardiomyopathy.
Am. J. Physiol.
Suppl. (Oct.) 261:
30-38,
1991.
38.
Saks, V. A.,
Rosenshtraukh L. V.,
Smirnov V. N.,
and
Chazov E. I.
Role of creatine phosphokinase in cellular function and metabolism.
Can. J. Physiol. Pharmacol.
56:
691-705,
1978[ISI][Medline]
39.
Savabi, F.
Free creatine available to the creatine phosphate energy shuttle in isolated rat atria.
Proc. Natl. Acad. Sci. USA
85:
7476-7480,
1988[Abstract/Free Full Text].
40.
Schneider, C.,
Stull G. A.,
and
Apple F. S.
Kinetic characterization of human heart and skeletal muscle CK isoenzymes.
Enzyme
39:
220-226,
1988[ISI][Medline].
41.
Seraydarian, M. W.,
Artaza L.,
and
Abbott B. C.
Creatine and the control of energy metabolism in cardiac and skeletal muscle cells in culture.
J. Mol. Cell Cardiol.
6:
405-413,
1974[ISI][Medline].
42.
Sipilä, I.,
Rapola J.,
Simell O.,
and
Vamas A.
Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina.
N. Engl. J. Med.
304:
867-870,
1981[Abstract].
43.
Snow, R. J.,
McKenna M. J.,
Selig S. E.,
Kemp J.,
Stathis C. G.,
and
Zhao S.
Effect of creatine supplementation on sprint exercise performance and muscle metabolism.
J. Appl. Physiol.
84:
1667-1673,
1998[Abstract/Free Full Text].
44.
Tonkonogi, M.,
Harris B.,
and
Sahlin K.
Mitochondrial oxidative function in human saponin-skinned fibers: effects of prolonged exercise.
J. Physiol. (Lond.)
510:
270-286,
1998.
45.
Vanderberghe, K.,
Goris M.,
Van Hecke P.,
Van Leemputte M.,
Vangerven L.,
and
Hespel P.
Long-term creatine intake is beneficial to muscle performance during resistance training.
J. Appl. Physiol.
83:
2055-2063,
1997[Abstract/Free Full Text].
46.
Veksler, V. K.,
Kuznetsov A. V.,
Anflous K.,
Mateo P.,
van Deursen J.,
Wieringa B.,
and
Ventura-Clapier R.
Muscle creatine kinase-deficient mice. II. Cardiac and skeletal muscles exhibit tissue-specific adaptation of the mitochondrial function.
J. Biol. Chem.
270:
19921-19929,
1995[Abstract/Free Full Text].
47.
Vøllestad, N. K.,
and
Blom P. C.
Effect of varying exercise intensity on glycogen depletion in human muscle fibres.
Acta Physiol. Scand.
125:
395-405,
1985[ISI][Medline].
48.
Yamashita, K.,
and
Yoshioka T.
Profiles of creatine kinase isoenzyme compositions in single muscle fibres of different types.
J. Muscle Res. Cell Motil.
12:
37-44,
1991[ISI][Medline].
J APPL PHYSIOL 88(4):1181-1191
8570-7587/00 $5.00
Copyright © 2000 the American Physiological Society